Cargando…
Classification of PD‐L1 expression in various cancers and macrophages based on immunohistocytological analysis
Programmed death (PD)‐1/PD‐ligand 1 (PD‐L1) antibodies have shown an intense clinical effect in some patients with PD‐L1(+) tumors, and their applications have rapidly expanded to various cancer types with or without the application of new companion diagnostics (CDx) with a lower cutoff value and in...
Autores principales: | Saito, Yoichi, Fujiwara, Yukio, Shinchi, Yusuke, Mito, Remi, Miura, Yuji, Yamaguchi, Tomoya, Ikeda, Koei, Urakami, Shinji, Nakashima, Yuta, Sakagami, Takuro, Suzuki, Makoto, Tabata, Yasuhiko, Komohara, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459416/ https://www.ncbi.nlm.nih.gov/pubmed/35633190 http://dx.doi.org/10.1111/cas.15442 |
Ejemplares similares
-
The expression of PD-1 ligand 1 on macrophages and its clinical impacts and mechanisms in lung adenocarcinoma
por: Shinchi, Yusuke, et al.
Publicado: (2022) -
SPP1 Derived from Macrophages Is Associated with a Worse Clinical Course and Chemo-Resistance in Lung Adenocarcinoma
por: Matsubara, Eri, et al.
Publicado: (2022) -
CD169
(+) sinus macrophages in regional lymph nodes do not predict mismatch‐repair status of patients with colorectal cancer
por: Saito, Yoichi, et al.
Publicado: (2023) -
Onionin A inhibits small-cell lung cancer proliferation through suppressing STAT3 activation induced by macrophages-derived IL-6 and cell–cell interaction with tumor-associated macrophage
por: Mito, Remi, et al.
Publicado: (2023) -
Accurate expression of PD‐L1/L2 in lung adenocarcinoma cells: A retrospective study by double immunohistochemistry
por: Shinchi, Yusuke, et al.
Publicado: (2019)